Werner Astrid C, Laver Nora V, Landmann Dan S
Tufts Medical Center - New England Eye Center, Boston, Massachusetts, USA.
Hackensack University Medical Center, Hackensack, New Jersey, USA.
Ocul Oncol Pathol. 2019 Feb;5(2):147-152. doi: 10.1159/000491381. Epub 2018 Aug 27.
Primary cutaneous follicle center lymphoma (PCFCL) is a unique entity that represents up to 11% of all cutaneous lymphomas. PCFCL is associated with an indolent course and excellent 5-year survival rates, but can progress to secondary systemic involvement if left untreated. Histopathologic features of PCFCL can vary depending on the size, duration, and clinical stage of the lesion, making diagnosis somewhat challenging. Here, we present a case of a 50-year-old woman with an eyelid lesion that was initially classified as an inflamed cyst based on biopsy, but 1 year later, was determined to be PCFCL after repeat biopsy revealed different histology. In light of the recent changes to the WHO classification of lymphoid neoplasms, we review the unique clinical and histopathologic features of PCFCL that distinguish it from other more aggressive forms of cutaneous lymphoma in terms of course, prognosis, and management.
原发性皮肤滤泡中心淋巴瘤(PCFCL)是一种独特的疾病实体,占所有皮肤淋巴瘤的11%。PCFCL病程进展缓慢,5年生存率高,但如果不治疗可能会进展为继发性全身受累。PCFCL的组织病理学特征会因病变的大小、持续时间和临床分期而有所不同,这使得诊断颇具挑战性。在此,我们报告一例50岁女性,其眼睑病变最初经活检被分类为炎性囊肿,但1年后,重复活检显示不同组织学特征,确诊为PCFCL。鉴于世界卫生组织(WHO)淋巴肿瘤分类的最新变化,我们回顾了PCFCL独特的临床和组织病理学特征,这些特征在病程、预后和管理方面使其有别于其他侵袭性更强的皮肤淋巴瘤形式。